Fundraising Fox
/Companies
Sign in

Oncodea

Saint Paul, US · Founded 2021 · Delaware corporation · 2 known investors

Find your way into Oncodea

Sign up to see every warm intro you have to Oncodea

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Oncodea team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Oncodea is a cancer research company developing early cancer detection and monitoring methods intended to be fast, affordable, and accessible to a broad population. It positions itself as more than a research lab, focused on making cancer testing inexpensive enough for regular use.

AI & Machine LearningBiotechDigital HealthHealthtech

Founders & leadership

AK
Ali KhammanivongNamed on SEC filing
DQ
Dan Que PhamNamed on SEC filing
YY
Yung-Ping YehNamed on SEC filing

Investors · 2

Tundra Ventureslisted by Tundra VenturesMinneapolis

How we know: Tundra Ventures's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$275.8K disclosed across 1 round · 2022

▶$275.8KraisedApr 2022 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ali KhammanivongDirector
  • Dan Que PhamExecutive Officer, Director
  • Yung-Ping YehDirector
Offering amount
$850K
Amount sold
$275.8K
Minimum investment
$25K
First sale
Apr 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

OncOnc.AI develops the Onclara platform, which uses oncology real-world data to build predictive and prognostic AI models for cancer decision-making. Its products serve pharma companies with Phase IB/II clinical trial decisions and predict immunotherapy response and outcomes for metastatic lung cancer patients.

Companies working in the same space as Oncodea.

Frequently asked questions

What does Oncodea do?
Oncodea is a cancer research company developing early cancer detection and monitoring methods intended to be fast, affordable, and accessible to a broad population. It positions itself as more than a research lab, focused on making cancer testing inexpensive enough for regular use.
Who are Oncodea's investors?
Oncodea's investors include GROOVE CAPITAL, Tundra Ventures.
How much funding has Oncodea raised?
Oncodea has disclosed $275.8K raised across 1 round.
Where is Oncodea headquartered?
Oncodea is headquartered in Saint Paul, US.